UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Has $32.94 Million Stock Position in HealthEquity, Inc. $HQY

Key Points

• UBS Asset Management increased its stake in HealthEquity by 1.6%, owning approximately 372,745 shares valued at approximately $32.94 million as of the latest reporting period.
• Analysts are optimistic about HealthEquity, with target prices being raised by multiple firms: Deutsche Bank raised theirs from $98.00 to $115.00 and JMP Securities from $110.00 to $117.00, reflecting a consensus rating of "Buy" with a target price of $119.77.
• HealthEquity's market performance shows a trading price of $93.02, with a 52-week high of $116.65 and a market capitalization of $8.01 billion.

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 1.6% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 372,745 shares of the company's stock after buying an additional 5,992 shares during the quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC owned approximately 0.43% of HealthEquity worth $32,939,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the business. Ieq Capital LLC boosted its stake in HealthEquity by 4.4% in the first quarter. Ieq Capital LLC now owns 2,945 shares of the company's stock valued at $260,000 after buying an additional 123 shares in the last quarter. Xponance Inc. boosted its stake in HealthEquity by 1.1% in the first quarter. Xponance Inc. now owns 12,412 shares of the company's stock valued at $1,097,000 after buying an additional 136 shares in the last quarter. Fifth Third Bancorp boosted its stake in HealthEquity by 17.5% in the first quarter. Fifth Third Bancorp now owns 955 shares of the company's stock valued at $84,000 after buying an additional 142 shares in the last quarter. AlphaQ Advisors LLC boosted its stake in HealthEquity by 5.1% in the first quarter. AlphaQ Advisors LLC now owns 3,430 shares of the company's stock valued at $303,000 after buying an additional 165 shares in the last quarter. Finally, State of Wyoming boosted its stake in HealthEquity by 2.9% in the first quarter. State of Wyoming now owns 5,915 shares of the company's stock valued at $523,000 after buying an additional 169 shares in the last quarter. 99.55% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

HQY has been the subject of several research reports. Deutsche Bank Aktiengesellschaft increased their target price on HealthEquity from $98.00 to $115.00 and gave the company a "buy" rating in a research report on Thursday, June 5th. JMP Securities increased their target price on HealthEquity from $110.00 to $117.00 and gave the company a "market outperform" rating in a research report on Wednesday, June 4th. Wall Street Zen upgraded HealthEquity from a "hold" rating to a "buy" rating in a research report on Friday, June 6th. Royal Bank Of Canada increased their target price on HealthEquity from $109.00 to $110.00 and gave the company an "outperform" rating in a research report on Wednesday, September 3rd. Finally, Barrington Research restated an "outperform" rating and set a $125.00 price objective on shares of HealthEquity in a research report on Friday, August 29th. One analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, HealthEquity currently has a consensus rating of "Buy" and a consensus target price of $119.77.

HealthEquity Trading Up 0.6%

Shares of HealthEquity stock opened at $93.02 on Tuesday. The company has a debt-to-equity ratio of 0.47, a quick ratio of 4.23 and a current ratio of 4.23. HealthEquity, Inc. has a 52 week low of $74.07 and a 52 week high of $116.65. The stock has a 50 day moving average price of $93.28 and a two-hundred day moving average price of $94.22. The stock has a market capitalization of $8.01 billion, a PE ratio of 56.38, a price-to-earnings-growth ratio of 1.33 and a beta of 0.50.

Insider Transactions at HealthEquity

In other HealthEquity news, EVP Michael Henry Fiore sold 1,794 shares of the company's stock in a transaction on Monday, July 7th. The stock was sold at an average price of $101.73, for a total value of $182,503.62. Following the completion of the transaction, the executive vice president owned 53,225 shares in the company, valued at $5,414,579.25. This represents a 3.26% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 1.50% of the company's stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.